Alan E. Walts, Ph. D.
Alan Walts, Ph. D., is a founding board member and currently serves as Executive Chairman of PIC Therapeutics. Alan also serves as Executive Chairman of Artax Biopharma, Chairman of Aura Biosciences, is a co-founder and Board Observer of Arrakis Therapeutics, a board observer at Amylyx Pharmaceuticals, and is a Director of the Termeer Foundation. Dr. Walts is a US-based Venture Partner with Advent Life Sciences and is an Advisory Board member of the ALS Investment Fund. He has over 25 years of industry experience at Genzyme in business development, business strategy, R&D, general management, and venture capital. Prior to leaving Genzyme in 2013, Dr. Walts most recently managed Genzyme’s corporate venture fund, Genzyme Ventures (now Sanofi Ventures). He received a PhD in chemistry from MIT in 1985, carried out post-doctoral research in biochemistry at MIT with Professor Christopher Walsh, and completed the executive Program for Management Development at Harvard Business School.